Welcome to Brianduriemd.myeloma.org - International Myeloma Foundation

brianduriemd.myeloma.org

Description: Brian Durie MD Myeloma. Dr. Durie founded and now serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board....

Google PR 0

Trustworthiness Good
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Good

International Myeloma Foundation | by Brian G.M. Durie, MD

Brianduriemd.myeloma.org: get to the top rated Brian Durie MD Myeloma pages and content popular with USA-based Brianduriemd.myeloma.org users or check the following digest to find out more. Brianduriemd.myeloma.org is a malware-free website without age restrictions, so you can safely browse it. It seems that Brianduriemd.myeloma.org team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Brianduriemd.myeloma.org is hosted with CloudFlare, Inc. in United States. Brian Durie MD Myeloma traffic is not yet estimated by Alexa.

Visit brianduriemd.myeloma.org

Domain info

Location:	United States
Registrant:	International Myeloma Foundation
Hosted by:	CloudFlare, Inc.
Registrar:	Public Interest Registry
Subnetworks:	104.22.56.192, 104.22.57.192, 172.67.11.54

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Brianduriemd.myeloma.org popular pages to visit

ICER Report: Could a flawed approach to cost-effectiveness assessment put patients at risk? | Multiple Myeloma: International Until earlier this year I was unfamiliar with ICER (Institute for Clinical and Economic Review).

Trial Results Show Impressive Benefit of Carfilzomib (Kyprolis®) versus Bortezomib (Velcade®) in Relapsed Myeloma | Dr. Durie's This week’s news of interim results from the ENDEAVOR trial, a head-to-head comparison of “real world” schedules of Kyprolis versus Velcade, reveals an impressive benefit of carfilzomib over bortezom...

Myeloma Experts, Not Bureaucrats, Should Create Treatment Recommendations for Patients | Dr. Durie's Blog In my previous blog, I wrote about the myeloma drug cost assessment report drafted by the Institute for Clinical and Economic Review (ICER). The potential contents of the ICER report continue to rais...